Literature DB >> 28656529

IL-22 Enhances TNF-α- and IL-1-Induced CXCL8 Responses by Intestinal Epithelial Cell Lines.

Rebecca S Young1, Brody M Wiles1, Dennis W McGee2.   

Abstract

IL-22 is known to induce intestinal epithelial cells (IECs) to produce the chemokine CXCL8. However, IECs exist in a cytokine network during mucosal inflammation, such that IL-22 must act in concert with potent pro-inflammatory cytokines like TNF-α and IL-1. Our studies show that IL-22 alone increased CXCL8 secretion from HT-29 cells, but the levels were minimal compared to that of the cells treated with TNF-α or IL-1 only. More significantly, co-stimulation with IL-22 and TNF-α enhanced both CXCL8 secretion and mRNA levels well over that of TNF-α stimulation alone. A similar enhancing effect was seen with IL-22- and IL-1-stimulated CXCL8 secretion. The enhancing effect of IL-22 on TNF-α-induced CXCL8 secretion was then determined to require the p38 MAPK, but not STAT1/3, PI3K, Akt, c-Jun N-terminal kinase, ERK, or IκBα. These experiments indicate that more significant effect of IL-22 on IECs responses may not be in inducing CXCL8 by itself, but in enhancing TNF-α- and IL-1-induced CXCL8 secretion to augment the contribution of IECs to local inflammatory responses.

Entities:  

Keywords:  CXCL8; IL-1; IL-22; TNF; intestinal epithelial; p38 MAPK

Mesh:

Substances:

Year:  2017        PMID: 28656529      PMCID: PMC5711566          DOI: 10.1007/s10753-017-0614-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

Review 1.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

Review 2.  Cytokine responses and epithelial function in the intestinal mucosa.

Authors:  Joseph C Onyiah; Sean P Colgan
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

3.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

4.  Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.

Authors:  Xiaoting Wang; Naruhisa Ota; Paolo Manzanillo; Lance Kates; Jose Zavala-Solorio; Celine Eidenschenk; Juan Zhang; Justin Lesch; Wyne P Lee; Jed Ross; Lauri Diehl; Nicholas van Bruggen; Ganesh Kolumam; Wenjun Ouyang
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

Review 5.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

Review 6.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

7.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

8.  Factors affecting Caco-2 intestinal epithelial cell interleukin-6 secretion.

Authors:  S J Vitkus; S A Hanifin; D W McGee
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

9.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 10.  The CXCL8-CXCR1/2 pathways in cancer.

Authors:  Qian Liu; Anping Li; Yijun Tian; Jennifer D Wu; Yu Liu; Tengfei Li; Yuan Chen; Xinwei Han; Kongming Wu
Journal:  Cytokine Growth Factor Rev       Date:  2016-08-25       Impact factor: 7.638

View more
  3 in total

1.  An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice.

Authors:  Qi Yin; Xuelei Pi; Yuanyuan Jiang; Guiping Ren; Zhihang Liu; Han Liu; Mengxia Wang; Wenying Sun; Siyu Li; Zhenqiu Gao; Deshan Li; Jiechao Yin
Journal:  Inflammation       Date:  2021-04-20       Impact factor: 4.092

2.  Identification of Immune Cell Landscape and Construction of a Novel Diagnostic Nomogram for Crohn's Disease.

Authors:  Hong Chen; Chunqiu Chen; Xiaoqi Yuan; Weiwei Xu; Mu-Qing Yang; Qiwei Li; Zhenyu Shen; Lu Yin
Journal:  Front Genet       Date:  2020-04-29       Impact factor: 4.599

3.  Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation.

Authors:  Dong-Xue Lu; Feng Liu; Hua Wu; Hai-Xia Liu; Bing-Yu Chen; Jing Yan; Yin Lu; Zhi-Guang Sun
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.